Difference between revisions of "Amyloid beta A4 peptide"
| Line 40: | Line 40: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 07:22, 25 July 2007
| Template:Infobox header| Amyloid beta A4 peptide | |
|---|---|
| Amyloid beta A4 peptide | |
| Substrate peptide name | Amyloid beta A4 peptide |
| Synonyms | Alzheimer disease amyloid protein |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; cerebrospinal fluid
Alzheimer's disease neuritic plaques |
| Swissprot ID | P05067 |
| Reactive glutamines | Q15 |
| Reactive lysines | K16, K28 |
| Substrate sequence | YEVHHQKLVFFA
DVGSNKGAIIG |
| Structure | 1AML |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7905838 |
| Notes | |
| Template:Infobox header | | |
